Navidea Biopharmaceuticals News

Express News | Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024

ReutersJul 3 16:30 ET

Navidea Biopharmaceuticals, Inc. Announces Special Meeting of Stockholders to Be Held July 8, 2024

BusinesswireJun 20 18:02 ET

Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend Its SEC Reporting Obligations

BusinesswireJan 26 19:05 ET

Navidea Settles Litigation With Capital Royalty, Stock Rallies 30%

Seeking AlphaDec 1, 2023 12:03 ET

Navidea Biopharmaceuticals, CRG Settle All Ongoing Litigation

RTTNewsDec 1, 2023 08:54 ET

Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release

BusinesswireDec 1, 2023 08:30 ET

Sector Update: Health Care

MT NewswiresOct 6, 2023 15:31 ET

Top Midday Decliners

MT NewswiresOct 6, 2023 14:14 ET

Navidea Biopharmaceuticals Faces Delisting From NYSE American, Plans to Move to OTC Markets

InvestingOct 6, 2023 01:14 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaSep 19, 2023 09:06 ET

12 Health Care Stocks Moving In Thursday's Intraday Session

BenzingaAug 17, 2023 13:31 ET

Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel

BusinesswireAug 10, 2023 09:29 ET

Why Navidea Biopharmaceuticals Shares Are Nosediving

BenzingaJul 31, 2023 09:39 ET

Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces Opportunities

BusinesswireJul 31, 2023 09:32 ET

12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaJul 31, 2023 09:06 ET

Navidea Biopharmaceuticals Received Written Notification That NYSE Is Determined To Commence Proceedings To Delist The Company's Stock; The Company's Board Will Appeal The Determination To Commence Delisting Proceedings

BenzingaJul 31, 2023 04:07 ET

12 Health Care Stocks Moving In Friday's After-Market Session

BenzingaJul 28, 2023 17:32 ET

NYSE American to Commence Delisting Proceedings Against Navidea Biopharmaceuticals, Inc. (NAVB)

BusinesswireJul 28, 2023 16:18 ET

Express News | Navidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA As Chief Financial Officer >NAVB

Moomoo 24/7Jul 27, 2023 17:20 ET

Express News | Navidea Biopharma Names Dana J Moss to Board; Amit Bhalla Steps Down

Moomoo 24/7Jul 13, 2023 17:10 ET